BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15714588)

  • 21. Scaffolds for microtubule inhibition through extensive modification of the epothilone template.
    Cachoux F; Isarno T; Wartmann M; Altmann KH
    Angew Chem Int Ed Engl; 2005 Dec; 44(45):7469-73. PubMed ID: 16240301
    [No Abstract]   [Full Text] [Related]  

  • 22. T-Taxol and the electron crystallographic density in beta-tubulin.
    Johnson SA; Alcaraz AA; Snyder JP
    Org Lett; 2005 Dec; 7(25):5549-52. PubMed ID: 16320988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A unified and quantitative receptor model for the microtubule binding of paclitaxel and epothilone.
    Wang M; Xia X; Kim Y; Hwang D; Jansen JM; Botta M; Liotta DC; Snyder JP
    Org Lett; 1999 Jul; 1(1):43-6. PubMed ID: 10822530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The microtubule-pore gatekeeper.
    Snyder JP
    Nat Chem Biol; 2007 Feb; 3(2):81-2. PubMed ID: 17235340
    [No Abstract]   [Full Text] [Related]  

  • 25. Derivation of dihedral angles from CH-CH dipolar-dipolar cross-correlated relaxation rates: a C-C torsion involving a quaternary carbon atom in epothilone A bound to tubulin.
    Carlomagno T; Sánchez VM; Blommers MJ; Griesinger C
    Angew Chem Int Ed Engl; 2003 Jun; 42(22):2515-7. PubMed ID: 12800174
    [No Abstract]   [Full Text] [Related]  

  • 26. Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site.
    Edler MC; Buey RM; Gussio R; Marcus AI; Vanderwal CD; Sorensen EJ; Díaz JF; Giannakakou P; Hamel E
    Biochemistry; 2005 Aug; 44(34):11525-38. PubMed ID: 16114889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineering enzymes for improved catalytic efficiency: a computational study of site mutagenesis in epothilone-B hydroxylase.
    Nayeem A; Chiang SJ; Liu SW; Sun Y; You L; Basch J
    Protein Eng Des Sel; 2009 Apr; 22(4):257-66. PubMed ID: 19179341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterologous production of epothilones B and D in Streptomyces venezuelae.
    Park SR; Park JW; Jung WS; Han AR; Ban YH; Kim EJ; Sohng JK; Sim SJ; Yoon YJ
    Appl Microbiol Biotechnol; 2008 Nov; 81(1):109-17. PubMed ID: 18769916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Making epothilones fluoresce: design, synthesis, and biological characterization of a fluorescent N12-aza-epothilone (azathilone).
    Gertsch J; Feyen F; Bützberger A; Gerber B; Pfeiffer B; Altmann KH
    Chembiochem; 2009 Oct; 10(15):2513-21. PubMed ID: 19760690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding tubulin-Taxol interactions: mutations that impart Taxol binding to yeast tubulin.
    Gupta ML; Bode CJ; Georg GI; Himes RH
    Proc Natl Acad Sci U S A; 2003 May; 100(11):6394-7. PubMed ID: 12740436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterizing the Epothilone Binding Site on β-Tubulin by Photoaffinity Labeling: Identification of β-Tubulin Peptides TARGSQQY and TSRGSQQY as Targets of an Epothilone Photoprobe for Polymerized Tubulin.
    Ranade AR; Higgins L; Markowski TW; Glaser N; Kashin D; Bai R; Hong KH; Hamel E; Höfle G; Georg GI
    J Med Chem; 2016 Apr; 59(7):3499-514. PubMed ID: 26986898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding the basis of drug resistance of the mutants of αβ-tubulin dimer via molecular dynamics simulations.
    Natarajan K; Senapati S
    PLoS One; 2012; 7(8):e42351. PubMed ID: 22879949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanical and functional properties of epothilone-stabilized microtubules.
    Yu D; Pessino V; Kuei S; Valentine MT
    Cytoskeleton (Hoboken); 2013 Feb; 70(2):74-84. PubMed ID: 23135951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformational preferences of natural and C3-modified epothilones in aqueous solution.
    Erdélyi M; Pfeiffer B; Hauenstein K; Fohrer J; Gertsch J; Altmann KH; Carlomagno T
    J Med Chem; 2008 Mar; 51(5):1469-73. PubMed ID: 18271516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tubulin and FtsZ structures: functional and therapeutic implications.
    Desai A; Mitchison TJ
    Bioessays; 1998 Jul; 20(7):523-7. PubMed ID: 9722999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural insight into epothilones antitumor activity based on the conformational preferences and tubulin binding modes of epothilones A and B obtained from molecular dynamics simulations.
    Jiménez VA; Alderete JB; Navarrete KR
    J Biomol Struct Dyn; 2015; 33(4):789-803. PubMed ID: 24773261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible binding site for paclitaxel at microtubule pores.
    Magnani M; Maccari G; Andreu JM; Díaz JF; Botta M
    FEBS J; 2009 May; 276(10):2701-12. PubMed ID: 19459933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The taxol pharmacophore and the T-taxol bridging principle.
    Kingston DG; Bane S; Snyder JP
    Cell Cycle; 2005 Feb; 4(2):279-89. PubMed ID: 15611640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, Biological Profiling and Determination of the Tubulin-Bound Conformation of 12-Aza-Epothilones (Azathilones).
    Jantsch A; Nieto L; Gertsch J; Rodríguez-Salarichs J; Matesanz R; Jiménez-Barbero J; Díaz JF; Canales Á; Altmann KH
    Molecules; 2016 Aug; 21(8):. PubMed ID: 27527129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiating between models of epothilone binding to microtubules using tubulin mutagenesis, cytotoxicity, and molecular modeling.
    Entwistle RA; Rizk RS; Cheng DM; Lushington GH; Himes RH; Gupta ML
    ChemMedChem; 2012 Sep; 7(9):1580-6. PubMed ID: 22807375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.